CC
ADMA icon

Cipher Capital’s ADMA Biologics ADMA Stock Holding History

Cipher Capital’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$78.3K Buy
+11,859
New +$64.8K 0.04% 408

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cipher Capital's ADMA Position: Q1 2024 in Review

Cipher Capital opened a new position in ADMA Biologics (ADMA) in Q1 2024: 11,859 shares worth $78.3K. The stake represents 0.04% of the portfolio and ranks #408 among its holdings.

214 funds tracked by Wall St. Rank hold ADMA as of Q1 2024.

  • Cipher Capital held 11,859 shares of ADMA Biologics worth $78.3K as of Q1 2024.
  • ADMA Biologics was a new Cipher Capital position in Q1 2024.
  • ADMA Biologics made up 0.04% of Cipher Capital's portfolio in Q1 2024, its #408 holding.
  • 214 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.